Online citations, reference lists, and bibliographies.
← Back to Search

Toxicity Of Therapeutic Nanoparticles.

Melissa A. Maurer-Jones, Kyle C Bantz, S. Love, Bryce J. Marquis, C. Haynes
Published 2009 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
A total of six nanotherapeutic formulations are already approved for medical use and more are in the approval pipeline currently. Despite the massive research effort in nanotherapeutic materials, there is relatively little information about the toxicity of these materials or the tools needed to assess this toxicity. Recently, the scientific community has begun to respond to the paucity of information by investing in the field of nanoparticle toxicology. This review is intended to provide an overview of the techniques needed to assess toxicity of these therapeutic nanoparticles and to summarize the current state of the field. We begin with background on the toxicological assessment techniques used currently as well as considerations in nanoparticle dosing. The toxicological research overview is divided into the most common applications of therapeutic nanoparticles: drug delivery, photodynamic therapy and bioimaging. We end with a perspective section discussing the current technological gaps and promising research aimed at addressing those gaps.
This paper references
10.1021/JA048548J
Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery.
Hui-Ting Chen (2004)
10.1083/JCB.119.3.493
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
Y. Gavrieli (1992)
Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.
D. Scudiero (1988)
10.1166/JNN.2008.171
Size dependent interactions of nanoparticles with lung surfactant model systems and the significant impact on surface potential.
Tabitha Ku (2008)
10.1021/NL0519229
Polymeric nanoparticle preparation that eradicates tumors.
J. Mccarthy (2005)
10.1021/nl0347334
Probing the Cytotoxicity Of Semiconductor Quantum Dots.
Austin M. Derfus (2004)
10.1021/NL047996M
Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles.
C. Kirchner (2005)
10.1021/NL050127S
Immunotargeted nanoshells for integrated cancer imaging and therapy.
C. Loo (2005)
10.1073/pnas.0601945103
Selective fluorescent imaging of superoxide in vivo using ethidium-based probes
K. M. Robinson (2006)
10.1016/0003-2697(90)90208-Q
Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples.
M. Baker (1990)
10.1016/j.addr.2008.03.018
Magnetic nanoparticles in MR imaging and drug delivery.
C. Sun (2008)
10.1016/J.IJPHARM.2006.03.052
Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
S. Azarmi (2006)
Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression.
I. Dransfield (1994)
Apoptosis : a practical approach
G. P. Studzinski (1999)
10.1158/1078-0432.CCR-04-2517
Anti-CD19-Targeted Liposomal Doxorubicin Improves the Therapeutic Efficacy in Murine B-Cell Lymphoma and Ameliorates the Toxicity of Liposomes with Varying Drug Release Rates
T. Allen (2005)
Investigations of fungal mediated ( C 60 – C 70 ) fullerene decomposition
SJ Bakri (2005)
10.1016/S1369-7021(05)00893-X
Magnetic nanoparticle probes
L. LaConte (2005)
10.1021/NL060860Z
The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications.
H. Vallhov (2006)
10.1021/NL062464M
Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin.
J. Rouse (2007)
10.1007/s11095-007-9284-6
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
L. E. V. Vlerken (2007)
10.1016/J.COPBIO.2007.11.008
Nanotoxicity: the growing need for in vivo study.
H. C. Fischer (2007)
10.1016/S0955-0674(99)00046-0
Cell proliferation and apoptosis.
M. Guo (1999)
Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles.
K. Sokolov (2003)
Malondialdehyde formation from lipid peroxides in the thiobarbituric acid test: the role of lipid radicals, iron salts, and metal chelators.
Gutteridge Jm (1983)
10.1016/0019-2791(71)90454-X
Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.
E. Engvall (1971)
10.1159/000087104
Cytokine Dysregulation, Inflammation and Well-Being
I. Elenkov (2005)
10.2174/156720107782151269
Liposomal drug delivery systems: an update review.
A. Samad (2007)
10.1182/BLOOD-2004-02-0655
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.
A. Arbab (2004)
10.1016/J.BIOMATERIALS.2007.04.004
Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.
Payal Agrawal (2007)
10.1016/J.BBAMEM.2006.01.009
Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations.
M. J. W. Johnston (2006)
10.1016/J.COPBIO.2006.11.001
Emerging concepts in molecular MRI.
D. Sosnovik (2007)
10.1016/J.BIOMATERIALS.2007.11.021
Efficient intracellular delivery of functional proteins using cationic polymer core/shell nanoparticles.
Ashlynn L. Z. Lee (2008)
10.1016/j.ijpharm.2007.11.036
Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
H. L. Ma (2008)
10.1038/nprot.2008.56
The selective detection of mitochondrial superoxide by live cell imaging
K. M. Robinson (2008)
10.1039/B706615E
Lethal photosensitisation of Staphylococcus aureus using a toluidine blue O-tiopronin-gold nanoparticle conjugate
J. Gil-Tomás (2007)
10.1016/j.ijpharm.2008.02.011
Inhaled nanoparticles--a current review.
W. Yang (2008)
10.1016/j.taap.2007.12.010
Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells.
J. Roberts (2008)
Targeting tumor angiogenesis using liposomes
RM Schiffelers (2007)
Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.
D. Bass (1983)
10.1021/NL0622707
Effect of C60 on solid supported lipid bilayers.
Tighe A. Spurlin (2007)
10.1016/J.BIOMATERIALS.2004.05.022
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
10.1063/1.2103936
Consideration Of The Toxicity of Manufactured Nanoparticles
M. Haasch (2005)
10.1007/s00216-008-2410-4
Delivering quantum dots into cells: strategies, progress and remaining issues
J. Delehanty (2009)
10.1023/B:PHAM.0000016249.52831.a5
Uptake and Cytotoxicity of Chitosan Molecules and Nanoparticles: Effects of Molecular Weight and Degree of Deacetylation
M. Huang (2004)
10.1016/J.COLSURFA.2007.04.152
Comparison of labeling efficiency of different magnetic nanoparticles into stem cell
Bo-Hyung Park (2008)
10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R
Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.
M. van Engeland (1998)
10.1021/ac800006y
Dynamic measurement of altered chemical messenger secretion after cellular uptake of nanoparticles using carbon-fiber microelectrode amperometry.
Bryce J. Marquis (2008)
10.1158/1535-7163.MCT-06-0412
Chemosensitization of carcinoma cells using epithelial cell adhesion molecule–targeted liposomal antisense against bcl-2/bcl-xL
Sajid Hussain (2006)
10.1016/J.ADDR.2005.09.019
Dendrimer biocompatibility and toxicity.
R. Duncan (2005)
10.1002/NBM.924
Iron oxide MR contrast agents for molecular and cellular imaging
J. Bulte (2004)
10.1021/nn700048y
In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos.
K. J. Lee (2007)
10.1021/NL052396O
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.
B. Chithrani (2006)
10.1080/02652040600775525
Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use
E. Ricci-Júnior (2006)
Iridium - complexfunctionalized Fe 3 O 4 / SiO 2 core / shell nanoparticles : A facile threeinone system in magnetic resonance imaging , luminescence imaging , and photodynamic therapy
CW Lai (2008)
10.2165/00137696-200503030-00002
Potential of transferrin and transferrin conjugates of liposomes in drug delivery and targeting
V. Soni (2005)
10.1038/nnano.2006.209
Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type.
K. Kostarelos (2007)
10.1016/J.TOXLET.2005.10.003
Acute toxicological effects of copper nanoparticles in vivo.
Z. Chen (2006)
10.1021/BM050480S
Novel monodisperse PEG-dendrons as new tools for targeted drug delivery: synthesis, characterization and cellular uptake.
M. Berna (2006)
10.1016/S1470-2045(06)70793-8
Emerging use of nanoparticles in diagnosis and treatment of breast cancer.
M. Yezhelyev (2006)
10.1364/OL.30.001012
Gold nanoshell bioconjugates for molecular imaging in living cells.
C. Loo (2005)
10.1201/9780849374555
Nanoparticle technology for drug delivery
R. B. Gupta (2006)
10.1002/smll.200700283
Iridium-complex-functionalized Fe3O4/SiO2 core/shell nanoparticles: a facile three-in-one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy.
C. Lai (2008)
Verteporfin ocular 89 photodynamic therapy
JG Christie (2004)
10.1211/jpp.58.4.0001
Can drug‐bearing liposomes penetrate intact skin?
Gamal M.M. El Maghraby (2006)
10.1073/PNAS.92.16.7162
Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures.
E. Bonfoco (1995)
10.1007/s10544-008-9180-9
Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs
G. Hong (2008)
Pharmacokinetics, toxicity, and efficacy of ends-modified raf antisense oligodeoxyribonucleotide encapsulated in a novel cationic liposome.
P. Gokhale (2002)
10.1093/TOXSCI/KFL165
Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments.
J. Teeguarden (2007)
10.1080/07366578308079439
Chemical and Physical Structure of Polymers as Carriers for Controlled Release of Bioactive Agents: A Review
R. Langer (1983)
10.1289/ehp.7339
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
G. Oberdörster (2005)
10.1259/BJR/28250432
Gold nanoparticles: a new X-ray contrast agent.
M. Geso (2007)
10.1016/0006-291X(84)90411-X
Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells.
O. Ostling (1984)
10.1016/0022-1759(83)90303-4
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
T. Mosmann (1983)
10.1021/NL061160X
Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells.
H. Dumortier (2006)
10.1038/nbt994
In vivo cancer targeting and imaging with semiconductor quantum dots
X. Gao (2004)
10.1002/9783527631117.CH13
PEGylated Polymer‐Based Nanoparticles for Drug Delivery to the Brain
H. Kim (2011)
10.1016/j.biomaterials.2008.07.025
The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis.
Liang-dong Chen (2008)
10.1016/J.IJPHARM.2006.06.008
Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation.
C. Huang (2006)
10.1167/IOVS.05-0495
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.
Amalia Enríquez de Salamanca (2006)
10.1016/j.bpc.2008.07.002
The effects of co-culture of fibroblasts on mast cell exocytotic release characteristics as evaluated by carbon-fiber microelectrode amperometry.
Bryce J. Marquis (2008)
10.1021/NL0710710
Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles.
C. Sayes (2007)
10.1021/TX700326B
Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles.
T. Laaksonen (2007)
10.1021/NL060177C
Oops they did it again! Carbon nanotubes hoax scientists in viability assays.
J. M. Wörle-Knirsch (2006)
10.1562/2004-05-24-RA-176.1
Photodynamic Characterization and In Vitro Application of Methylene Blue-containing Nanoparticle Platforms¶
Wei Tang (2005)
10.1007/s00395-008-0710-7
Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications
D. Sosnovik (2008)
10.1517/17425247.4.2.95
Liposome-based drug delivery to alveolar macrophages
S. Vyas (2007)
10.2217/17435889.3.1.83
Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives.
H. Zhang (2008)
10.1016/J.TOXLET.2006.11.001
Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants.
K. Pulskamp (2007)
10.1016/J.TOX.2006.05.001
Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis.
T. Mori (2006)
10.1016/J.JMMM.2005.01.064
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
T. Neuberger (2005)
Nanoparticle Based Photodynamic Therapy for Cancer
W. Chen (2006)
10.1016/0022-1759(91)90198-O
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.
I. Nicoletti (1991)
10.1016/0006-3002(63)90513-4
STUDIES ON SUCCINATE-TETRAZOLIUM REDUCTASE SYSTEMS. III. POINTS OF COUPLING OF FOUR DIFFERENT TETRAZOLIUM SALTS.
T. F. Slater (1963)
10.1126/SCIENCE.39.1004.443
THE ACTION OF VITAL STAINS BELONGING TO THE BENZIDINE GROUP.
H. Evans (1914)
10.1016/J.FREERADBIOMED.2007.05.005
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism.
P. Mróz (2007)
10.1007/s00395-008-0711-6
Contrast agents for MRI
E. A. Waters (2008)
10.1111/J.1745-7270.2005.00108.X
Caspase family proteases and apoptosis.
T. Fan (2005)
10.1038/444267a
Safe handling of nanotechnology
Andrew D. Maynard (2006)
10.1016/J.BIOMATERIALS.2006.11.028
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
Y. Diebold (2007)
10.1021/nl0720408
Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging.
K. Hartman (2008)
10.1074/jbc.M408829200
Yersinia Phosphatase Induces Mitochondrially Dependent Apoptosis of T Cells*
Shane Bruckner (2005)
10.1021/NL072471Q
Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles.
D. Giljohann (2007)
10.1517/14656566.5.1.195
Verteporfin ocular photodynamic therapy
S. Bakri (2004)
10.1016/S0891-5849(99)00061-1
Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123.
S. Hempel (1999)
10.1021/LA061879K
Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging.
C. Zhang (2007)
10.1016/J.JMMM.2005.02.061
Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer
Raoul Kopelman (2005)
10.1021/BM049200J
Novel functionalized biodegradable polymers for nanoparticle drug delivery systems.
P. Kallinteri (2005)
10.1002/ANIE.200301758
Semiconductor quantum dots as biological imaging agents.
M. Green (2004)
10.1080/08958370701479323
Proinflammogenic Effects of Low-Toxicity and Metal Nanoparticles In Vivo and In Vitro: Highlighting the Role of Particle Surface Area and Surface Reactivity
R. Duffin (2007)
10.1126/SCIENCE.1104274
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
X. Michalet (2005)
In vitro and in vivo activities of verteporfinloaded nanoparticles
A Khdair (2005)
10.1016/0022-1759(91)90377-R
Measurement of antigen specific lymphocyte proliferation using 5-bromo-deoxyuridine incorporation. An easy and low cost alternative to radioactive thymidine incorporation.
P. L. Huong (1991)
10.1016/S0167-7012(93)80010-4
Reliability of calcein acetoxy methyl ester and ethidium homodimer or propidium iodide for viability assessment of microbes
E. Kaneshiro (1993)
10.1016/J.JCONREL.2007.09.002
Photosensitiser-loaded biodegradable polymeric micelles: preparation, characterisation and in vitro PDT efficacy.
C. Rijcken (2007)
10.1186/1477-3155-5-6
Self assembly of amphiphilic C60 fullerene derivatives into nanoscale supramolecular structures
Ranga Partha (2007)
10.1016/J.ACRA.2004.04.018
Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
H. Choi (2004)
10.1007/s10439-005-9002-7
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
D. Thorek (2005)
10.1016/J.CANLET.2005.07.035
Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles.
I. El-Sayed (2006)
10.1016/J.PROGPOLYMSCI.2007.09.003
Polymeric nanomedicine for cancer therapy
J. Park (2008)
10.1093/CLINCHEM/34.3.497
A simple method for clinical assay of superoxide dismutase.
Y. Sun (1988)
10.1016/J.BIOMATERIALS.2005.03.034
Interactions between endothelial cells and a poly(carbonate-silsesquioxane-bridge-urea)urethane.
G. Punshon (2005)
10.1186/1743-8977-2-8
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
G. Oberdörster (2005)
10.1002/1520-6017(200103)90:3<288::AID-JPS4>3.0.CO;2-5
Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir.
M. Fresta (2001)
10.1016/j.ejpb.2008.08.017
Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
Ayman Khdair (2009)
10.1016/J.IJPHARM.2006.08.044
Multivariate toxicity screening of liposomal formulations on a human buccal cell line.
G. Smistad (2007)
10.1021/LA0607499
Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity.
Srinivasan Ramachandran (2006)
10.1158/1078-0432.CCR-06-0946
Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors
G. R. Reddy (2006)
10.1016/J.TCB.2004.07.012
Potentials and pitfalls of fluorescent quantum dots for biological imaging.
Jyoti K. Jaiswal (2004)
10.1016/j.drudis.2007.12.005
Ophthalmic light sensitive nanocarrier systems.
Jennifer G Christie (2008)
10.1007/978-1-59259-427-6_9
Liposomal Drug Delivery Systems for Cancer Therapy
D. Drummond (2004)
10.1016/0272-0590(88)90314-4
Structure-activity relationships for diorganotins, chlorinated benzenes, and chlorinated anilines established with bluegill sunfish BF-2 cells.
H. Babich (1988)
10.1002/ijc.22709
Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles
Y. Liu (2007)
10.1016/S0014-5793(99)00696-1
Ratio‐fluorescence microscopy of lipid oxidation in living cells using C11‐BODIPY581/591
E. Pap (1999)
10.1093/TOXSCI/KFM018
Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
C. Sayes (2007)
10.1021/ES062541F
Visualizing the uptake of C60 to the cytoplasm and nucleus of human monocyte-derived macrophage cells using energy-filtered transmission electron microscopy and electron tomography.
A. Porter (2007)
10.1021/NL0603350
Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements.
T. Zhang (2006)
10.1021/BM0506905
Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL.
E. Chnari (2006)
10.1201/9781420006636.CH36
Solid Lipid Nanoparticles for Anti-Tumor Drug Delivery
H. L. Wong (2006)
10.1016/J.PROGSOLIDSTCHEM.2005.11.010
Magnetic nanoparticle design for medical applications
S. Mornet (2006)
10.1080/08958370701758742
Concordance Between In Vitro and In Vivo Dosimetry in the Proinflammatory Effects of Low-Toxicity, Low-Solubility Particles: The Key Role of the Proximal Alveolar Region
K. Donaldson (2008)
Contrast agents for 121 MRI
Gao XCY (2008)
10.1016/j.biopha.2008.07.087
Meso-tetra (carboxyphenyl) porphyrin (TCPP) nanoparticles were internalized by SW480 cells by a clathrin-mediated endocytosis pathway to induce high photocytotoxicity.
Z. Hu (2009)
10.1016/J.JCONREL.2004.11.023
In vitro and in vivo activities of verteporfin-loaded nanoparticles.
Y. Konan-Kouakou (2005)
10.1002/smll.200700595
Cytotoxicity of nanoparticles.
Nastassja Lewinski (2008)
10.1038/SJ.JID.5700508
Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes.
Jessica P. Ryman-Rasmussen (2007)
10.1021/nn7004393
High-content screening as a universal tool for fingerprinting of cytotoxicity of nanoparticles.
E. Jan (2008)
10.2217/17435889.3.1.73
Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells.
D. Chatterjee (2008)
10.1039/B602830F
Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse'.
M. Wieder (2006)
10.1016/J.BIOMATERIALS.2003.12.046
Cell response to dextran-derivatised iron oxide nanoparticles post internalisation.
C. Berry (2004)
10.1016/J.EJPB.2007.06.009
Quantum dots - nano-sized probes for the exploration of cellular and intracellular targeting.
W. Hild (2008)
10.1007/s00109-004-0629-x
Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots
Jasmina Lovrić (2004)
Magnetic 117 nanoparticle probes
AK Gupta (2005)
10.1007/s10646-008-0205-1
Manufactured nanoparticles: their uptake and effects on fish—a mechanistic analysis
R. Handy (2008)



This paper is referenced by
10.1039/b9nr00132h
Nanotechnology for in vitro neuroscience.
Daniel R Cooper (2009)
10.1007/s12274-014-0697-3
How toxic are gold nanoparticles? The state-of-the-art
I. Fratoddi (2015)
10.1163/092050610X535680
Effect of Modification Manner on the Photodynamic Antitumor Activity of C60 Modified with Pullulan
Jian Liu (2011)
Gold nanoparticles: Applications and in vitro cytotoxicity
Diego Mateo (2013)
10.1016/j.ijpharm.2011.04.025
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes.
D. Belletti (2011)
10.2147/IJN.S37481
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
A. Orza (2013)
10.19080/AIBM.2017.05.555658
Gold Nanoparticles: Their Application as i Antimicrobial Agents and Vehicles of Gene Delivery
S. Kundu (2017)
10.1007/s00216-010-3843-0
Bioanalytical tools for single-cell study of exocytosis
Shencheng Ge (2010)
10.1007/S11051-011-0251-0
The bench scientist’s perspective on the unique considerations in nanoparticle regulation
Bryce J. Marquis (2011)
10.1007/978-3-030-44552-2_8
Nanotechnology Applications to Improve Solubility of Bioactive Constituents of Foods for Health-Promoting Purposes
Silvana Alfei (2020)
10.1109/COMST.2017.2705740
Molecular Communication and Nanonetwork for Targeted Drug Delivery: A Survey
U. Chude-Okonkwo (2017)
10.1016/j.ejps.2010.06.012
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma.
B. Ruozi (2010)
10.1039/b913967b
Amperometric assessment of functional changes in nanoparticle-exposed immune cells: varying Au nanoparticle exposure time and concentration.
Bryce J. Marquis (2009)
10.2147/IJN.S25853
Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model
Yu-Lan Hu (2011)
10.1186/1743-8977-7-22
Nanomaterial cytotoxicity is composition, size, and cell type dependent
S. Sohaebuddin (2009)
10.1007/978-1-61779-052-2_1
Biomedical nanotechnology.
Sarah J. Hurst (2011)
10.2174/0929867321666140815124246
Diagnostic and therapeutic uses of nanomaterials in the brain.
E. Garbayo (2014)
Multimodal nanoparticles for quantitative imaging
de A Vries (2011)
10.1002/ADFM.200901846
Investigations on the Structural Damage in Human Erythrocytes Exposed to Silver, Gold, and Platinum Nanoparticles
P. Asharani (2010)
10.1201/B14595-7
Quantum Dot Reactive Oxygen Species Generation and Toxicity in Bacteria: Mechanisms and Experimental Pitfalls
Jay L. Nadeau (2013)
10.1002/smll.200902084
High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signaling.
S. Soenen (2010)
Magnetic fl uid hyperthermia : Focus on superparamagnetic iron oxide nanoparticles
S. Laurent (2011)
10.15761/fnn.1000176
Understanding the safety aspect of biologically synthesized agriculturally useful nanomaterials for humans and environment
Ayushi Priyam (2018)
10.1007/978-1-60761-609-2_1
What is cancer nanotechnology?
S. Grobmyer (2010)
10.4155/fmc.10.249
Drug delivery to the CNS and polymeric nanoparticulate carriers.
L. Costantino (2010)
10.1039/c3an01601c
Centrifugation-based assay for examining nanoparticle-lipid membrane binding and disruption.
A. Xi (2014)
10.1002/cmmi.282
Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes.
S. Soenen (2009)
10.1016/j.jcis.2011.04.080
Preparation and characterization of highly stable lipid nanoparticles with amorphous core of tuneable viscosity.
Thomas Delmas (2011)
10.2147/DDDT.S58414
Improving anticancer efficacy of (–)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells
Cheng-cheung Chen (2014)
10.1088/1468-6996/14/4/044407
Non-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systems
Yu-Cheng Chen (2013)
10.1111/j.1748-720X.2012.00707.x
Toward Correlation in In Vivo and In Vitro Nanotoxicology Studies
Melissa A. Maurer-Jones (2012)
10.1007/11663_2015_13
Monitoring the Impact of Nanomaterials on Animal Cells by Impedance Analysis: A Noninvasive, Label-Free, and Multimodal Approach
Michaela Sperber (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar